Total Bilirubin
Total bilirubin measures the amount of bilirubin in the blood, which is a byproduct of the normal breakdown of red blood cells. It is used to assess liver function and diagnose conditions such as jaundice, anemia, and liver diseases.
Total bilirubin is a key indicator of liver health and red blood cell breakdown.
Key facts at a glance
- Units
- mg/dL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche Bilirubin, Abbott Bilirubin, Siemens Bilirubin
Total bilirubin is the sum of direct (conjugated) and indirect (unconjugated) bilirubin in the blood. It is a critical marker for evaluating liver function and detecting diseases such as hepatitis, cirrhosis, and hemolytic anemia.
Elevated levels of total bilirubin can lead to jaundice, a condition characterized by yellowing of the skin and eyes. This can be due to liver damage, bile duct obstruction, or increased red blood cell breakdown.
Normal levels of total bilirubin range from 0.2 to 1.2 mg/dL. Levels above this range may indicate liver dysfunction, bile duct problems, or increased red blood cell destruction.
Frequently asked questions
What causes high total bilirubin levels?
How is total bilirubin tested?
Sources
- 1
- 2
- 3Liver Function TestsSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy